Delta Gold Technologies (LON: DGQ), the quantum computing IP developer, has raised £1.92m through subscriptions at 35p/share. Every two shares come with a warrant to subscribe for shares at 50p each. This cash will help to accelerate university agreements and collaborations. New shareholders include Purebond. The share price jumped 16.7% to 42p.
EPE Special Opportunities Fund (LON: EO.P) says that it does not intend to buyback any more shares. It has already acquired 1.25 million shares. The share price rose 8.24% to 184p.
Connecting Excellence (LON: XCE) shares have begun trading on the OTC Venture Market (OTCQB) in the US. The share price improved 4.17% to 1.25p.
ProBiotix Health (LON: PBX) reassured investors that it has no direct connection with skin treatments developer SkinBioTherapeutics (LON: SBTX), which has been hit by the departure of the chief executive and accounting adjustments, even though they were both spun out of OptiBiotix Health (LON: OPTI). Michael Litichevski, who is vice president, sales, of ProBiotix Health, bought 45,100 shares at 6.5p each. The share price rebounded from an early loss ending the week 3.23% higher at 8p.
FALLERS
Valereum (LON: VLRM) has signed a memorandum of understanding with Integra Foundation to establish “a framework to collaborate on real-world asset tokenisation, institutional distribution, and secondary trading, with an initial focus on real estate”. This could help to accelerate revenue generation. The share price declined 13% to 10p.
The wife of BWA Holdings (LON: BWAP) non-exec John Byfield has bought 1.98 million shares at 0.25p each, taking their joint holding to 0.79%. The share price slipped 10% to 0.225p.
Digital asset miner Sterling Digital (LON: ASIC) has bought 450 ASIC Bitcoin mining servers at a lower cost than budgeted, as well as modular, high-density, hydro-cooled data centre infrastructure for these mining servers. Initial production should be in the second quarter of 2026. The share price dipped 5.26% to 4.5p.
Arbuthnot Banking (LON: ARBB) says that it made good progress in the fourth quarter of 2025. Pre-tax profit will be at the upper end of the guidance range of £22m-£24m. A total dividend of 53p/share is forecast. The share price slid 4.49% to 850p.
EDX Medical (LON: EDX) has raised £3.5m at 14p/share. That is the same share price as the previous fundraising. The proceeds will accelerate the prostate cancer programme to develop diagnostic products. The share price fell 3.85% to 12.5p.